46XiJCAB
New Fish
Big Pharma has run out of disease states that effect enough people to be hugely profitable. High blood pressure, reflux, diabetes, asthma, COPD, pain management, psych disorders. All have multiple options from various pharmaceutical companies. So they come out with next generations that offer minimal clinically significant improvements in outcomes for patients. And cost more. Then that plays out. So where do you go to keep the lights on?
They take a asthma controller with a $4 copay and corticosteroid that's first generation. No money in that. So they create a new inhalation delivery system and now your copay is $50. You can remove the new delivery system and activate the device in the exact same manner as the $4 device. Yup, it's all about patients.
Covid will be their next windfall.
They take a asthma controller with a $4 copay and corticosteroid that's first generation. No money in that. So they create a new inhalation delivery system and now your copay is $50. You can remove the new delivery system and activate the device in the exact same manner as the $4 device. Yup, it's all about patients.
Covid will be their next windfall.